Lantheus Earnings
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 100.15 0.00%
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$1.01
Lantheus earnings summary
Lantheus is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $1.01. In its most recent report on Aug 6, 2026 (Q2 2026), LNTH posted EPS of $1.11. Revenue for the quarter was $388.2 million.
Quarterly EPS is down 0.9% from the same quarter a year earlier. Across the last 16 reports, LNTH shares moved an average of 4.1% (in either direction) in the first trading session after results, rising 6 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
LNTH earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $1.11 | — | 0.0% |
| May 7, 2026 | — | $1.80 | — | +0.9% |
| Feb 26, 2026 | — | $0.86 | — | -3.1% |
| Nov 6, 2025 | — | $0.41 | — | +3.8% |
| Aug 6, 2025 | — | $1.12 | — | -5.3% |
| May 7, 2025 | — | $1.02 | — | -0.6% |
| Feb 26, 2025 | — | $-0.18 | — | +13.3% |
| Nov 6, 2024 | — | $1.79 | — | -12.2% |
| Jul 31, 2024 | — | $0.88 | — | -0.3% |
| May 2, 2024 | — | $1.87 | — | +0.6% |
| Feb 22, 2024 | — | $1.48 | — | -2.5% |
| Nov 2, 2023 | — | $1.88 | — | -1.3% |
| Aug 3, 2023 | — | $1.33 | — | -8.8% |
| May 4, 2023 | — | $-0.04 | — | +5.9% |
| Feb 23, 2023 | — | $-1.68 | — | +0.7% |
| Nov 3, 2022 | — | $0.86 | — | -6.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.